In Canada, OSA is listed as one of the qualifying weight-related conditions under the chronic weight management label meaning a patient with OSA and a BMI of 27 or higher may qualify for Zepbound but the approved use is weight management, not OSA treatment
For example, if a manufacturer can demonstrate compliance with current GMP standards, validated analytical controls, and appropriate safety data, could structured or conditional pathways be considered that allow responsible distribution while full approval is pursued
Why does this article call dosing flexibility a difference between the two options
For a broader understanding of peptide safety across different compounds, our guide on safe peptides for women and peptides for women over 40 address gender-specific safety considerations
If you choose to drink, taking an extra dose of glutathione before bed or the next morning may help support the liver's recovery process
Our treatment provides a comprehensive plan that incorporates these medications alongside a well-balanced diet and regular exercise